Beta
15603

Effectiveness of Alizapride for Prophylaxis of Nausea and Vomiting after Spinal Anesthesia for Cesarean Section

Article

Last updated: 03 Jan 2025

Subjects

-

Tags

-

Abstract

Background: Nausea and vomiting are common side effects in parturients undergoing cesarean delivery performed under spinal anesthesia can be very unpleasant to the patients. The reported incidence of nausea and vomiting during cesarean performed under regional anesthesia varies from 50% to 80% when no prophylactic antiemetic is given. Therefore, use of prophylactic antiemetics in parturients undergoing cesarean delivery is recommended by some authors. Objective: In this study, alizapride was evaluated, as a D2 receptor antagonist, on the prevention of nausea and vomiting following Spinal Anesthesiain parturients undergoing elective cesarean section. Patients and Methods: The study was carried out in AL-Azhar University Hospitals, Obstetric and gynaecology department on 90 patients undergoing an elective, lower segment cesarean section (LSCS). All patients were identified by code number to maintain the privacy of the patients. Any unexpected risks appeared during the course of the research was cleared to the participants and the ethical committee on time. A written informed consent was obtained from all patients.  Patients were divided into 3 groups, 30 patients for each group. Group I (Alizapride 50 group):  Received intravenous (IV) Alizapride 50 mg diluted in 10 ml of normal saline over 1-5 minutes, immediately after clamping umbilical cord. Group II (Alizapride 100 group): Received intravenous (IV) Alizapride 100 mg diluted in 10 ml of normal saline over 1-5 minutes, immediately after clamping umbilical cord. Group III (Saline group):  Received normal saline 10 ml, immediately after clamping umbilical cord. Results: The incidence of nausea and vomiting was significantly decreased in group 2 (Alizapride100 group) compared with group 1 (Alizapride 50 group) and both group was better than group 3 (control group). The use of ondansetron and chlorpheniramine was significantly decreased in group 1 and 2 when compared with group 3. Conclusion: This study concluded that Alizapride 100 mg, given intravenously immediately after clamping umbilical cord would reduce PONV and pruritus in parturients undergoing an elective cesarean section under spinal anesthesia.

DOI

10.21608/ejhm.2018.15603

Keywords

Postoperative nausea and vomiting, cesarean section, Alizapride

Authors

First Name

Ayman Hussein Fahmy

Last Name

Kahla

MiddleName

-

Affiliation

Department of Anesthesia & Intensive Care, Faculty of Medicine, Al-Azhar University

Email

-

City

-

Orcid

-

First Name

Nasr Abdel-Aziz Mohammad

Last Name

Saad

MiddleName

-

Affiliation

Department of Anesthesia & Intensive Care, Faculty of Medicine, Al-Azhar University

Email

-

City

-

Orcid

-

First Name

Islam Mahmoud Mohamed

Last Name

Mahmoud

MiddleName

-

Affiliation

Department of Anesthesia & Intensive Care, Faculty of Medicine, Al-Azhar University

Email

shamosa2014@gmail.com

City

-

Orcid

-

Volume

73

Article Issue

5

Related Issue

3385

Issue Date

2018-10-01

Receive Date

2018-10-02

Publish Date

2018-10-01

Page Start

6,633

Page End

6,640

Print ISSN

1687-2002

Online ISSN

2090-7125

Link

https://ejhm.journals.ekb.eg/article_15603.html

Detail API

https://ejhm.journals.ekb.eg/service?article_code=15603

Order

7

Type

Original Article

Type Code

606

Publication Type

Journal

Publication Title

The Egyptian Journal of Hospital Medicine

Publication Link

https://ejhm.journals.ekb.eg/

MainTitle

Effectiveness of Alizapride for Prophylaxis of Nausea and Vomiting after Spinal Anesthesia for Cesarean Section

Details

Type

Article

Created At

22 Jan 2023